Development of co-solvent freeze-drying method for the encapsulation of water-insoluble thiostrepton in sterically stabilized micelles

被引:12
作者
Esparza, Karina [1 ]
Onyuksel, Hayat [1 ,2 ]
机构
[1] Univ Illinois, Dept Biopharmaceut Sci, Chicago, IL 60612 USA
[2] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA
关键词
DSPE-PEG(2000); Thiostrepton; Co-solvent freeze-drying; Antibiotic nanomedicine; Sterically stabilized micelles; Drug encapsulation; PHOSPHOLIPID MICELLES; BREAST-CANCER;
D O I
10.1016/j.ijpharm.2018.12.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this work was to develop a practical and scalable method to encapsulate the hydrophobic antibiotic thiostrepton (TST) in sterically stabilized micelles (SSM). Using the conventional method of thin-film hydration, we encapsulated up to 5 drug molecules per SSM (diameter similar to 16 nm). However, since this method is not suitable for large-scale production - a limiting factor for clinical translation - we applied the co-solvent freeze-drying method using tert-butanol (TBA): water co-solvent system. We found that the presence of phosphate-buffered saline (PBS) salts in the lyophilized cake accelerated the reconstitution time and allowed efficient drug encapsulation without the formation of larger drug particles. In addition, TBA proportion of 50% (v/v) was sufficient to maintain both phospholipid and drug in solution prior to the freeze-drying. The increase of drug and phospholipid concentrations in the formulation extended the reconstitution time and led to drug precipitation. Therefore, to increase the strength of the formulation, we prepared lyophilized cakes with lower phospholipid content (5 mM) and reconstituted them in one-third of the fill volume. In conclusion, we found optimum conditions to prepare TST-SSM using the co-solvent freeze-drying method. This scalable production method can facilitate the further clinical development and industrial production of TST-SSM nanomedicine.
引用
收藏
页码:21 / 29
页数:9
相关论文
共 23 条
[1]   In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization:: Effects of PEG chain length and PC incorporation [J].
Ashok, B ;
Arleth, L ;
Hjelm, RP ;
Rubinstein, I ;
Önyüksel, H .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (10) :2476-2487
[2]   Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound [J].
Baka, Edit ;
Comer, John E. A. ;
Takacs-Novak, Krisztina .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 46 (02) :335-341
[3]   Interactions of the N-terminal domain of ribosomal protein L11 with thiostrepton and rRNA [J].
Bausch, SL ;
Poliakova, E ;
Draper, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (33) :29956-29963
[4]   Insights into the influence of the cooling profile on the reconstitution times of amorphous lyophilized protein formulations [J].
Beech, Karen E. ;
Biddlecombe, James G. ;
van der Walle, Christopher F. ;
Stevens, Lee A. ;
Rigby, Sean P. ;
Burley, Jonathan C. ;
Allen, Stephanie .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2015, 96 :247-254
[5]  
DONOVICK R, 1955, Antibiot Annu, V3, P554
[6]   A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers [J].
Fournier, E ;
Dufresne, MH ;
Smith, DC ;
Ranger, M ;
Leroux, JC .
PHARMACEUTICAL RESEARCH, 2004, 21 (06) :962-968
[7]   Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: a novel therapeutic approach for breast cancer and breast cancer stem cells [J].
Guelcuer, Ece ;
Thaqi, Mentor ;
Khaja, Fatima ;
Kuzmis, Antonina ;
Oenyueksel, Hayat .
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2013, 3 (06) :562-574
[8]  
International Council on Harmonisation of Technical Require-ments for Pharmaceuticals for Human Use, 2016, IMP GUID RES SOLV Q3
[9]  
JAMBOR W P, 1955, Antibiot Annu, V3, P562
[10]   Thiopeptide Antibiotics: Retrospective and Recent Advances [J].
Just-Baringo, Xavier ;
Albericio, Fernando ;
Alvarez, Mercedes .
MARINE DRUGS, 2014, 12 (01) :317-351